Aurora Towers Announces Niko Veilleux as a Member of the Board of Directors

MONTRÉAL, Oct. 20, 2026 /PRNewswire/ -- Aurora Towers today announced that Niko Veilleux has joined the company's leadership team as a member of the Board of Directors.

Niko brings vast experience across the legal, telecommunications, and financial sectors. He is a partner at Osler, Hoskin & Harcourt LLP, where he leads the firm's Corporate Group in Montréal and is a member of the firm's Partnership Board. With more than 25 years of practice, he has advised public and private companies, private equity sponsors, pension funds, boards of directors and special committees on mergers and acquisitions, private equity investments, capital markets transactions and corporate governance. He has significant experience and expertise in the telecommunications sector, having advised Québecor and Videotron on their acquisition of Freedom Mobile, among other transactions in the industry. Niko has taught mergers and acquisitions law at McGill University's Faculty of Law. He holds B.C.L. and LL.B. degrees from McGill University and completed the Program for Leadership Development at Harvard Business School. He is recognized by Chambers Canada, Lexpert, Best Lawyers and The Legal 500.

Niko commented, "I am pleased to join the Board of Directors of Aurora Towers and to contribute my legal and governance perspective as the company continues to expand its role as one of Canada's leading independent owner, operator, and developer of wireless telecommunications infrastructure. As our economy becomes ever more dependent on digital connectivity, I'm excited to help the Aurora team navigate an evolving telecommunications landscape while advancing its mission to deliver resilient and secure infrastructure for communities across the country."

Martin Pinnes, Chief Executive Officer of Aurora Towers, commented, "On behalf of the Board and the Company, we are very pleased to welcome Niko as our newest director. He brings a deep understanding of corporate governance, complex transactions, and the evolving regulatory environment that shapes Canada's wireless infrastructure landscape. As we continue to invest in and expand our portfolio, Niko's strategic insight will be invaluable in supporting disciplined growth, strengthening our partnerships with the wireless carriers and communities, and advancing our commitment to long-term value for all shareholders."

Aurora Towers welcomes Niko to the board and looks forward to benefiting from his counsel as the company continues to execute on its growth strategy under the team's current leadership.

SOURCE Aurora Towers

Share this article

SAN JOSE, Oct. 20, 2026 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced it will release its third quarter 2026 financial results after the market close on Monday, November 2, 2026. Harmonic will host a live webcast to discuss the Company's results at 2:00 p.m. PT on the same day.

To participate via telephone, please register in advance using this link, https://register-conf.media-server.com/register/BI3ab9c6deda3a4df08222bd943609a117.

Upon registration, telephone participants will receive a confirmation email detailing how to join the audio version of the webcast, including the dial-in number and a unique registrant ID. The live webcast will be available via Harmonic's Investor Relations website at https://investor.harmonicinc.com/. The Company suggests participants for both the conference call and those listening via the web dial in or sign on at least 15 minutes in advance of the call.

For those unable to participate in the live event, a replay will be available on the same website after 5:00 p.m. PT.

Further information about Harmonic and the Company's solutions is available at https://www.harmonicinc.com/.

About Harmonic

Harmonic (NASDAQ: HLIT), the worldwide leader in virtualized broadband solutions, is transforming multi-gigabit connectivity. The Company's industry-leading cOS™ virtualized broadband platform, suite of solutions for fiber and DOCSIS, and a growing portfolio of AI-powered network intelligence solutions enable broadband service providers to simplify operations, deliver exceptional subscriber experiences and expand revenue streams. With thousands of vCMTS servers and hundreds of thousands of RPDs deployed globally, Harmonic powers next-generation broadband services with five-nines reliability. Anchored with a customer-first approach and driven by a legacy of innovation, Harmonic supports broadband service providers at every stage of their network evolution. More information is available at www.harmonicinc.com. 

Harmonic, the Harmonic logo and other Harmonic marks are owned by Harmonic Inc. or its affiliates. All other trademarks referenced herein are the property of their respective owners.

SOURCE Harmonic Inc.

Share this article

NEW YORK, Oct. 20, 2026 /PRNewswire/ -- TEN Holdings, Inc. ("XHLD" or the "Company") (Nasdaq: XHLD), the technology company behind TEN, a Digital Experience Platform for creating, producing, engaging, marketing and measuring digital experiences, today announced that Virgilio Torres, Chairman & Chief Executive Officer will be delivering a live corporate presentation on Tuesday, October 27 at 12:00 p.m. ET via the Skyline Signature Series.

About The Skyline Signature Series

The Skyline Signature Series is Skyline Corporate Communications Group, LLC's proprietary branded live virtual webinar event that provides public companies with a convenient and effective forum to communicate their story to a diverse audience of financial professionals through live virtual presentations. Following the corporate presentation, a Q&A session will be held whereby audience members will have the opportunity to submit their questions, which will then be answered live by Ten Holdings management.

Presentation Details

Presenter: Virgilio Torres, Chairman & Chief Executive Officer

Date: Tuesday, October 27, 2026

Time: 12:00 p.m. ET

Location: Virtual

Fee to Attend: Free

Registration Link: 

https://events.skylineccg.com/SkylineSignatureSeriesTenHoldingsIncNasdaqXHLD 

"The Skyline Signature Series offers Ten Holdings an ideal opportunity to connect with both current and prospective shareholders," remarked Mr. Torres. "By participating in events like this, we can effectively share our story and innovative solutions with a broader audience of investors, industry leaders, and potential partners, all while reinforcing our commitment to transparent communication with our shareholders."

About TEN Holdings, Inc.

TEN Holdings, Inc. (Nasdaq: XHLD), headquartered in New York is a technology company built around TEN, a Digital Experience Platform for creating, producing, engaging, marketing and measuring digital experiences, beginning with enterprise events, webinars and continuing education. TEN scales up to 50,000 concurrent attendees and is backed by more than a decade of experience producing mission-critical corporate broadcasts for Fortune 500 clients. The Company plans to expand TEN beyond events and webinars, including AI and automation, landing pages, integrations, engagement, reporting and analytics, and content studio. There can be no assurance as to the timing or availability of these capabilities. To learn more, visit www.tenholdingsinc.com.

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including, but not limited to, risks regarding the Company's growth strategy, the development, availability and adoption of TEN and its planned expansion, including AI and automation, landing pages, integrations, engagement, reporting and analytics, and content studio capabilities, the Company's recurring-revenue strategy, potential acquisitions, and the uncertainties related to market conditions and other factors discussed in the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC") and other filings with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and TEN Holdings, Inc. specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

For more information, please contact:

Investor Relations Inquiries:

Skyline Corporate Communications Group, LLC

Scott Powell, President

1177 Avenue of the Americas, 5th Floor

New York, New York 10036

Office: (646) 893-5835

Email: [email protected] 

SOURCE TEN Holdings, Inc.

Share this article

NEW ORLEANS, Oct. 20, 2026 /PRNewswire/ -- Answer ALS announced that the National Football League (NFL) has committed $500,000 to Champion Insights, a nationwide research study investigating why elite athletes, military veterans, and first responders develop ALS at higher rates than the general public. The study aims to uncover genetic and biological factors that may help explain this increased risk and ultimately lead to new treatments and strategies to prevent ALS.

The commitment was announced October 5 on Good Morning America during an interview with Answer ALS founder Steve Gleason, a former New Orleans Saints player and leading ALS advocate. Gleason, diagnosed with ALS in 2011, was the study's first participant.

On the broadcast, Gleason emphasized the importance of moving beyond speculation to understand the underlying causes of ALS.

"That is not a rumor. It is a fact we have to face with honesty and urgency. I do not spend time on speculation. I spend it asking why. That is the purpose of Champion Insights. We believe the answers will be found in our biology and the traits that come with high-performance lives," Gleason said.

"The NFL has demonstrated a longstanding commitment to the ALS community, and we are incredibly grateful for that support," said Clare Durrett, Managing Director of Answer ALS. "What makes this investment especially meaningful is the NFL's willingness to help us look deeper into the genetic and biological factors that may contribute to increased ALS risk. We want to understand not just who is more vulnerable, but why. Those answers could be important for everyone facing this disease, and ultimately help us find ways to treat and prevent ALS."

People in these high-intensity professions may face up to twice the risk of ALS compared with the general population. Champion Insights, launched earlier this year, is enrolling up to 500 participants through remote participation, including in-home blood collection and comprehensive surveys examining genetics, lifestyle, environmental exposures, and other potential contributing factors.

The study builds on the established research infrastructure of Answer ALS and the ALS Therapy Development Institute's ARC study, applying comprehensive biological and clinical data collection methods to populations with a documented higher risk of ALS. By examining these groups more closely, researchers hope to uncover biological mechanisms that may be relevant to ALS across the broader population.

"As an aviator, we trained to perform at our best, physically, mentally, and professionally," said Matt Bellina, retired U.S. Navy Lieutenant Commander and person living with ALS. "That pursuit of excellence is something we take pride in. But science is beginning to explore whether some of the same biological traits that drive high performance may also contribute to increased ALS risk. Champion Insights is asking why, and those answers could benefit everyone facing this disease. We owe it to every warrior, competitor, and family impacted by ALS to keep searching."

Champion Insights is led by Answer ALS and Augie's Quest to Cure ALS, with research conducted by the ALS Therapy Development Institute and guidance from the Champion Insights Advisory Board, which includes leading experts in ALS research. The study's ultimate goal is to translate discoveries about increased risk into a better understanding of ALS biology, paving the way for more targeted treatments and strategies to prevent the disease for everyone.

For more information about Champion Insights participation eligibility or to enroll, please visit the Champion Insights website or contact [email protected].

Media can access the Champion Insights overview video and review the full digital media kit, including b-roll, images, and background materials, at the Champion Insights media resources page.

About Answer ALS

Answer ALS is the most comprehensive ALS research consortium in history, producing more ALS data and biological samples than has ever been amassed, while openly sharing with the global research community. These data and samples are used to investigate the unique pathways of each variation of ALS and begin to develop and test the right treatments or cure. Answer ALS is an unprecedented approach to understanding and defeating the disease. Headquartered in New Orleans and Washington, D.C., Answer ALS stands at the forefront of global efforts to eradicate the disease, supported by research partners and advocates worldwide.

For more information, visit us at answerals.org, LinkedIn, X, Facebook and Instagram.

About ALS TDI

The ALS Therapy Development Institute (ALS TDI) is the first and largest nonprofit research institute dedicated solely to discovering and inventing effective treatments for ALS.

ALS TDI takes a multifaceted approach to ending ALS—inventing and advancing targeted treatments, identifying causes and risk factors, and cultivating a research ecosystem in which ALS drug development is effective and efficient. In its state-of-the-art labs, ALS TDI researchers drive drug discovery across multiple stages, working to advance the many therapies necessary for addressing the various types of ALS. alstdi.net, LinkedIn, X, Facebook and Instagram.

About Augie's Quest

Founded by Augie Nieto, Augie's Quest to Cure ALS is the unwavering force driving breakthroughs in ALS research, defying limitations, and empowering hope for a future without this devastating disease. We are dedicated to funding innovative research to find effective treatments and ultimately a cure, while advancing the field and translating scientific knowledge into real-world solutions. For more information, visit us at augiesquest.org, LinkedIn, X, Facebook and Instagram.

Media Contacts:

Kissy Black

Answer ALS

[email protected]

Roxan Triolo Olivas

Lotos Nile

[email protected]

SOURCE Answer ALS

Share this article

Chubb Reports Third Quarter Per Share Net Income and Record Core Operating Income of $7.30 and $7.66, Respectively, Up 4.4% and 0.8%; Consolidated Net Premiums Written of $15.1 Billion, Up 1.9%, with P&C and Life Insurance Up 1.9% and 1.4%; P&C Combined Ratio of 84.1%; Record Year-to-Date Per Share Net Income and Core Operating Income of $20.46 and $21.94, Up 16.2% and 24.5%, Respectively; Annualized Return on Equity (ROE) of 14.5% and Core Operating ROE of 14.6%

- Net income was $2.84 billion, up 1.5%, and core operating income was $2.98 billion, down 2.2%. For the nine months, net income and core operating income were a record $8.02 billion and $8.60 billion, respectively, up 12.9% and 21.0%.

- P&C net premiums written were $13.18 billion, up 1.9%.

- North America Commercial was down 2.7%, or up 1.7% excluding large account property including E&S and financial lines underwriting related exposure changes including additional reinsurance.

- North America Personal was up 5.3%.

- North America Agriculture was up 5.1%.

- Overseas General was up 6.7%, or 5.2% in constant dollars. Consumer insurance was up 7.2% and commercial insurance was up 6.3%; Latin America, Asia and Europe were up 11.7%, 7.5% and 6.8%, respectively.

- P&C underwriting income was $2.06 billion, with a combined ratio of 84.1%. P&C current accident year underwriting income excluding catastrophe losses was $2.26 billion, up 3.3%, with a combined ratio of 82.6%. For the nine months, P&C underwriting income was $5.79 billion, up 33.7%, and was $6.39 billion, up 6.1%, on a current accident year excluding catastrophe losses basis. Both were records.

- Total pre-tax net catastrophe losses were $705 million compared with $285 million in the prior year.

- Total pre-tax favorable prior period development was $511 million compared with $361 million in the prior year.

- Life Insurance net premiums written were $1.96 billion, up 1.4%, or 3.7% in constant dollars. International life insurance net premiums written and deposits collected were $2.44 billion, up 15.7%, or 18.6% in constant dollars. Life Insurance segment income was $369 million, up 11.4%, or 14.7% in constant dollars, with International Life income up 7.0%, or 10.9% in constant dollars. For the nine months, Life Insurance segment income was $1.03 billion, up 9.3%, or 10.0% in constant dollars, with International Life income up 10.8%, or 11.8% in constant dollars.

- Pre-tax net investment income was $1.79 billion, up 8.6%, and adjusted net investment income was $1.89 billion, up 6.3%. Both were records.

- Annualized return on equity (ROE) was 15.3%. Annualized core operating return on tangible equity (ROTE) was 21.6% and annualized core operating ROE was 14.9%.

- Book value and tangible book value per share increased 5.1% and 5.7%, respectively, from September 30, 2025. Tangible book value per share excluding AOCI was up 15.4% over the same period.

ZURICH, Oct. 20, 2026 /PRNewswire/ -- Chubb Limited (NYSE: CB) today reported net income for the quarter ended September 30, 2026 of $2.84 billion, or $7.30 per share, and core operating income of $2.98 billion, or $7.66 per share. Book value per share and tangible book value per share increased by 5.1% and 5.7%, respectively, from September 30, 2025 and now stand at $191.43 and $126.96. For the last three months, book value was unfavorably impacted by after-tax net realized and unrealized losses of $4.48 billion in Chubb's investment portfolio, partially offset by $551 million of foreign currency gains. Book value per share and tangible book value per share excluding AOCI increased by 11.1% and 15.4% from September 30, 2025.

Effective Q3 2026, segment income and core operating income have been redefined to exclude intangible amortization expenses related to purchased intangibles other than long-term distribution agreements. Refer to "Regulation G – Non-GAAP Financial Measures" in this press release and the Table of Contents page in the Q3 2026 Chubb Limited Financial Supplement for additional information. Prior-period results have been restated to reflect these changes.

For the nine months ended September 30, 2026, net income was $8.02 billion, or $20.46 per share, and core operating income was $8.60 billion, or $21.94 per share. Book value per share and tangible book value per share increased by 1.5% and 0.6%, from December 31, 2025. For the last nine months, book value was unfavorably impacted by after-tax net realized and unrealized losses of $6.03 billion in Chubb's investment portfolio, partially offset by $643 million of foreign currency gains. Book value per share and tangible book value per share excluding AOCI increased by 7.4% and 10.1%, from December 31, 2025.

For the nine months ended September 30, 2026 and 2025, the tax expenses (benefits) related to the table above were $6 million and $47 million, respectively for adjusted net realized gains and losses; $(7) million and nil for integration expenses and severance; $(7) million and $(38) million for market risk benefits gains and losses; $(33) million and $(36) million for amortization of fair value adjustments; and $2.09 billion and $1.75 billion for core operating income.

Evan G. Greenberg, Chairman and Chief Executive Officer of Chubb Limited, commented: "We had a really strong quarter with strong contributions from all of our businesses. Our diversification is highly supportive of growth and sustained margins which speak to our underwriting discipline, a hallmark of our company.

"P&C underwriting, investment and life income results led to core operating earnings of $2.98 billion, or $7.66 per share. Due to particularly light CAT losses last year, earnings are down 2% and up 1% per share from 2025. For the first nine months of the year, which is a more meaningful perspective, core operating income is a record $8.6 billion, or $21.94 per share, up 21% and 24.5%, respectively, from the prior year.

"Annualized core operating return on tangible equity is 21.6% and core operating ROE is 14.9%. Tangible book value per share is up 5.7% from the prior year. This was impacted by the mark-to-market due to higher interest rates. Adjusting for AOCI, tangible book value per share increased 15.4%.

"For the quarter, P&C underwriting income is $2.1 billion, which led to a combined ratio of 84.1%, and on a current accident year ex-CAT basis, our combined ratio is 82.6%, simply excellent. Year-to-date underwriting income of $5.8 billion is up nearly 34% from 2025.

"On the investment side of our business, adjusted net investment income is a record $1.9 billion, supported by rising interest rates and an excellent fixed-income investment environment, which we have been anticipating for some time, given government deficits and the capital investment cycle. On the alternative asset side, as publicly announced in the quarter, Strategic Holdings, our holding company partnership with KKR, agreed to sell our investment in USI Insurance Services to Aon, which is expected to result in a realized gain of $460 million on an investment of $740 million.

"While the market continues to grow more competitive in commercial P&C across the board, particularly in the U.S. and London, the substantial majority of our underwriting businesses grew in the quarter, with the balance flat or purposely shrinking due to inadequate pricing or terms.

"We are benefiting from our diversification. Overseas General grew 6.7%, with Latin America up 11.7%, Asia up 7.5% and Europe up about 7%. North America personal lines was up 5.3% and agriculture was up 5.1%. North America commercial was down 2.7%, impacted by a reduction in exposure, including increased use of reinsurance and underwriting related non-renewal actions, predominantly property and financial lines-related. I fully expect North America commercial growth to improve in future quarters.

"Our deep local presence and capabilities globally, our large and growing invested asset along with rising interest rates, and operating discipline provide us continued growth opportunities and sustainability of value creation. I am confident in our ability to continue to outperform and to generate strong growth in operating earnings and EPS and, most important, double-digit growth in tangible book value."

Operating highlights for the quarter ended September 30, 2026 were as follows:

- Consolidated net premiums earned increased 3.9%, or 4.0% in constant dollars. P&C net premiums earned increased 4.3%, or 4.0% in constant dollars.

- Operating cash flow was $6.07 billion and adjusted operating cash flow was $5.55 billion. Both were records.

- Total capital returned to shareholders in the quarter was $1.57 billion, comprising share repurchases of $1.18 billion at an average purchase price of $344.32 per share and dividends of $393 million. Total capital returned to shareholders for the nine months was $4.47 billion, comprising share repurchases of $3.30 billion at an average purchase price of $332.33 per share and dividends of $1.17 billion.

Details of financial results by business segment are available in the Chubb Limited Financial Supplement. Key segment items for the quarter ended September 30, 2026 are presented below:

- North America Commercial P&C Insurance: The combined ratio increased 4.8 percentage points, including a 3.1 percentage point increase from higher CATs, a 1.0 percentage point increase in the underlying loss ratio and a 0.3 percentage point increase in the underlying expense ratio with the acquisition ratio up, both driven by shift in mix of business, primarily due to reduction in property business.

- North America Personal P&C Insurance: The combined ratio decreased 4.8 percentage points, including a 4.3 percentage point decrease from higher favorable prior period development (PPD) and a 2.2 percentage point decrease in the underlying loss ratio, partially offset by a 1.7 percentage point increase from higher CATs.

THOUSAND OAKS, Calif., Oct. 20, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the European Society of Medical Oncology Congress (ESMO) 2026 on Saturday, October 24, 2026 at 11:30 a.m. PT. Murdo Gordon, executive vice president of Global Markets and Policy at Amgen, and Jean-Charles Soria, senior vice president of oncology within Global Development at Amgen, as well as other members of Amgen's management team, will discuss Amgen's oncology portfolio and selected data being presented at ESMO 2026. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 30 days after the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, YouTube and Threads.

CONTACT: Amgen, Thousand Oaks

Brianna Wilkins, 513-284-9807 (media)

Casey Capparelli, 805-447-1746 (investors) 

SOURCE Amgen

Share this article

TRAVERSE CITY, Mich., Oct. 20, 2026 /PRNewswire/ -- Hagerty, Inc. (NYSE: HGTY), a business that makes it easier and more enjoyable to be a driving enthusiast, today announced it will report its third quarter 2026 financial results before the market opens on Tuesday, November 3, 2026.

Hagerty will hold a conference call to discuss the financial results at 10:00 am Eastern Time on that day. A live webcast of the conference call will be available on Hagerty's investor relations website at investor.hagerty.com. To dial-in for the conference call, please register using the link found here to receive your unique dial-in and PIN.

A webcast replay of the call will be available at investor.hagerty.com following the call.

About Hagerty, Inc. (NYSE: HGTY)

Hagerty is a company built by drivers for drivers, protecting 3.0 million vehicles in the United States, Canada and the UK. We make it easier and more enjoyable for enthusiasts to drive and celebrate the machines they love through innovative insurance products, live and digital auctions, engaging media and events, and the Hagerty Drivers Club, the world's largest membership community of car lovers.

For more information, please visit www.hagerty.com or www.newsroom.hagerty.com.

Category: Financial

Source: Hagerty

SOURCE Hagerty

Share this article

LONDON, Oct. 20, 2026 /PRNewswire/ -- The "Dairy Blends Market - Growth, Share, Opportunities & Competitive Analysis, 2025-2035" report has been added to the Credence Research Inc. market intelligence offering.

The global dairy blends market was valued at USD 9.97 billion in 2025 and is estimated at USD 10.40 billion in 2026. Revenue is projected to reach USD 15.38 billion by 2035, with a stated CAGR of 4.43% over 2025-2035. The cost gap between milk fat and vegetable fats, shelf-stable milk substitutes and industrial ingredient demand are supporting dairy blend sales. Asia Pacific held 30.2% of 2025 revenue, while Africa is the fastest-growing region in the Credence Research model. Market sizes and segment and regional shares are Credence Research estimates.

Key Takeaways

- Credence Research estimates the dairy blends market at USD 9.97 billion in 2025 and forecasts USD 15.38 billion in 2035, a 4.43% CAGR.

- Fat-filled milk powders led by type with 35.5% of 2025 value and have the fastest modeled growth at 5.43%.

- Powder products held 61.0% of 2025 revenue, supported by shelf life and easier transport.

- Asia Pacific held 30.2% of 2025 value; Africa accounted for 20.4% and is modeled to grow fastest at 5.68%.

- Arla Foods and DMK Group officially united in June 2026, strengthening European dairy production scale.

- Dairy naming rules, input-price swings and import policy remain major constraints.

Scope & Segmentation - Dairy Blends Market

Fat-filled milk powders, dairy ingredient blends, spreadable butter blends and filled evaporated or condensed milk. Straight milk powders, butter, infant formula and products containing no dairy ingredients are excluded.

By type: Fat-filled milk powders; dairy ingredient blends; spreadable butter blends; filled evaporated and condensed milk.

By application: Household and reconstituted milk; spreads and table use; bakery and confectionery; beverages and creamers; ice cream and frozen desserts; prepared foods and foodservice.

By form: Powder; spreadable; liquid.

By region: Asia Pacific; Europe; Africa; North America; Middle East; Latin America.

Explore the full market report: Dairy Blends Market

Why This Report Matters

- Separates blended dairy products from straight dairy commodities and non-dairy substitutes.

- Shows how ingredient economics, cold-chain limitations and consumer price sensitivity shape geographic demand.

- Tracks 2026 cooperative mergers and portfolio transactions that affect milk sourcing, brands and processing capacity.

Market Overview

Dairy blends combine dairy components with other ingredients to meet cost, texture or handling requirements. Fat-filled milk powder typically substitutes part of expensive milk fat with vegetable fat while retaining milk protein. Spreadable blends target convenience and performance in mature retail markets, while tailored dairy ingredient blends serve bakery, beverages and foodservice.

Powders have particular value in import-dependent markets because they are comparatively easy to transport and store without refrigeration. The forecast assumes that the price difference between milk fat and vegetable oils remains sufficient to support substitution, while producers retain access to compliant ingredients and local distribution channels.

Market Insights

- Fat-filled milk powders accounted for 35.5% of 2025 type revenue.

- Spreads and table use led application value at 23.7%, while household and reconstituted milk is the fastest-growing application at 5.26%.

- Powder was the largest form with a 61.0% share in 2025.

- Asia Pacific led at 30.2%, while Africa was modeled to grow fastest at 5.68%.

Key Attributes

Segmentation

By type

Fat-filled milk powders; dairy ingredient blends; spreadable butter blends; filled evaporated and condensed milk.

By application

Household and reconstituted milk; spreads and table use; bakery and confectionery; beverages and creamers; ice cream and frozen desserts; prepared foods and foodservice.

By form

Powder; spreadable; liquid.

By region

Asia Pacific; Europe; Africa; North America; Middle East; Latin America.

Market Drivers and Growth Dynamics

The relative cost of milk fat is the central economic driver. In price-sensitive markets, replacing part of milk fat with vegetable fat can lower the price of a reconstituted product. The savings are important in West Africa and Southeast Asia, where shelf-stable powders support distribution across markets with limited refrigeration.

Food factories also value consistent ingredient blends that simplify procurement and processing. A supplier able to tailor protein, fat and solids to a customer's specification can secure repeat orders after qualification. European spreadable blends compete more on texture, convenience and brand position than on the lowest cost.

Regional Analysis

Asia Pacific held 30.2% of 2025 market value, supported by powder and filled milk products in Southeast Asia and ingredient demand in larger food manufacturing markets. Europe followed with 25.7%, where butter blends and specialized dairy ingredients are established.

Africa accounted for 20.4% and is the fastest-growing region in the model at 5.68% annually. Imported fat-filled powder serves markets with significant demand for affordable reconstituted milk. Import substitution policies and currency volatility are important risks.

North America held 8.9%, the Middle East 8.3% and Latin America 6.5%. North American demand centers on industrial ingredients and retail blends, while the Gulf and Latin America use a mix of imported powder and food-processing ingredients. Shares are Credence Research estimates.

Market Challenges

Dairy-product naming and labeling rules limit how products containing vegetable fat may be marketed. Exporters must also navigate destination-country standards and import policies. A product positioned as affordable milk in one jurisdiction may require different labeling in another.

Both dairy and vegetable fats are volatile inputs. Blenders can face temporary margin pressure when procurement costs change faster than customer contract prices. Traceability requirements and shifts in import duties add operating complexity for smaller suppliers.

Future Outlook

Credence Research expects shelf-stable powders in Africa and Asia to contribute much of the incremental value through 2035. Europe should remain an important market for spreadable blends and specialized ingredients. Larger cooperatives and processors may improve sourcing efficiency, but their performance will depend on commodity prices and local market access.

Competitive Landscape

Arla Foods, FrieslandCampina, Lactalis, Ornua, Tirlán, Lakeland Dairies and Fonterra participate through dairy production, brands or ingredient supply. Alpen Food Group, Dana Dairy Group, Promasidor and Vreugdenhil Dairy Foods serve powder and blended-product channels. Danone participates in related consumer dairy and creamer categories. The merger of Arla and DMK, Fonterra's Mainland divestiture and the FrieslandCampina-Milcobel merger changed ownership structures in 2026. These corporate events do not establish market-share rankings for dairy blends.

Key Players

- Arla Foods

- FrieslandCampina

- Lactalis

- Ornua

- Tirlán

- Lakeland Dairies

- Alpen Food Group

- Dana Dairy Group

- Promasidor

- Vreugdenhil Dairy Foods

- Fonterra

Recent Developments

June 2026: Arla Foods and DMK Group officially united, creating a larger farmer-owned dairy cooperative with a combined milk pool of 19.4 billion kilograms annually.

March 2026: Fonterra completed the sale of its Mainland Group consumer and associated businesses to Lactalis.

January 2026: The FrieslandCampina and Milcobel cooperative merger took effect following membership approvals announced in December 2025.

Report Coverage

The Dairy Blends Market study evaluates market size and forecast growth, the segmentation categories listed above, regional demand patterns, relevant policy and technology developments, supplier positioning and commercialization risks. It covers the 2025 base year and forecasts to 2035. The report distinguishes modeled estimates from independently disclosed company transactions and regulatory events.

The research supports strategy, investment screening, market entry and competitive benchmarking. Figures should be interpreted within the report's stated revenue boundaries; they are not independently audited market totals. Forecast outcomes depend on the adoption, pricing and regulatory assumptions discussed in the analysis.

Explore the full market report: Dairy Blends Market

Related Credence Research Reports

https://www.credenceresearch.com/report/uk-clean-label-starch-market

https://www.credenceresearch.com/report/food-emulsifiers-market

https://www.credenceresearch.com/report/insect-feed-market

https://www.credenceresearch.com/report/wheat-starch-market

https://www.credenceresearch.com/report/soluble-fibers-market

https://www.credenceresearch.com/report/cbd-snacks-market

About Us

Credence Research Inc. is a global market intelligence and consulting firm founded in 2015. It provides quantitative research, market forecasts, competitive intelligence and strategic guidance to business leaders, investors, governments and other organizations across a broad range of industries.

The firm develops market reports and customized research covering industry structure, demand drivers, technology trends, company positioning and regional opportunities.

Contact Us

Credence Research Inc.

Tower C-1105, S 25, Akash Tower

Vishal Nagar, Pimple Nilakh, Haveli

Pune - 411027, India

Europe Phone: +44 7453 598 606

US Phone: +1 6282 627 656

Email: [email protected] 

Website: https://www.credenceresearch.com/ 

SOURCE Credence Research Inc.

Share this article

JACKSONVILLE, Fla., Oct. 20, 2026 /PRNewswire/ -- Renue By Science, a longevity-focused wellness company specializing in NAD+ formulations, today announced the release of its latest whitepaper on Renue Blue Moisturizing Body Cream. The whitepaper reports results from a four-week consumer perception study, conducted with Citruslabs, of how women perceived changes in visible signs of body skin aging, including dryness, rough texture, fine lines, and crepey skin.

Dry, crepey, and less-firm skin on the arms, legs, and hands is one of the most common skin concerns among women over 30. Yet anti-aging research has focused mostly on the face, and products made for aging body skin have received far less study.

Renue Blue Moisturizing Body Cream was formulated to fill that gap. It combines longevity-focused ingredients, antioxidants, peptides, and botanical extracts. At its core is a liposomal complex of NAD+, NMN, NR, and Methylene Blue. Liposomal encapsulation is designed to help deliver these ingredients deeper into the skin for better absorption. Methylene Blue also works alongside CoQ10 and green tea extract as part of the formula's antioxidant defense. The rest of the formula is built around three goals:

- Hydration and comfort: Squalane, caprylic/capric triglycerides, and coconut oil help lock in moisture through the day.

- Barrier support: Rice lipids and chia seed extract help reinforce the skin's natural barrier.

- Firmness: Palmitoyl Tripeptide-5, together with NMN and NR, supports visibly firmer, more resilient skin.

In the new study, 40 women aged 30 to 65 with at least one self-reported visible sign of body skin aging applied the cream once daily for four weeks; 38 completed the study. Participants reported benefits early, and the benefits grew over time:

- Fast-acting hydration: 84% agreed their skin felt more hydrated by Day 3.

- Smoother, more even skin: 95% reported smoother skin at Week 4, and 89% reported improvement in rough or uneven areas.

- Visible aging concerns: 89% reported an improved appearance of fine lines, and 84% agreed crepey-looking areas appeared reduced and their skin felt firmer.

- Higher self-rated scores: On a 0–10 scale, mean hydration scores rose from 4.74 to 8.22, and mean scores for the appearance of crepey skin rose from 5.03 to 7.76.

- High satisfaction: 95% were satisfied with their results, and 92% would recommend the cream to family and friends.

"Body skin has been largely overlooked in skin aging research, even though concerns like crepey skin on the arms and legs come up constantly with the women we hear from," said Rebecca Crews, Ph.D., Research Director at Renue By Science. She added, "We built Renue Blue around liposomal NAD+ precursors and Methylene Blue, and we wanted to hear directly from women using it. Most noticed their skin felt more hydrated within just a few days, and the results kept improving over the four weeks."

Renue By Science is committed to developing science-backed products and to transparency in how they are evaluated. The company continues to invest in human research across its portfolio.

This was a virtual, single-arm consumer perception study; results reflect participants' self-reported perceptions.

SOURCE Renue By Science

Share this article

AKRON, Ohio, Oct. 20, 2026 /PRNewswire/ -- The Goodyear Tire & Rubber Company (NASDAQ: GT) will report third quarter 2026 financial results after market close on Wednesday, November 4, followed by a conference call at 8:30 a.m. Eastern time on Thursday, November 5.

The Company will publish its results on November 4, in the form of an Earnings Release and an additional presentation on its investor website: http://investor.goodyear.com. The following morning, the Company will host a conference call.

The call can be accessed on the website or via telephone by calling either (833) 419-0865 or (785) 838-9333 before 8:25 a.m. and providing the conference ID "Goodyear." A replay will be available by calling (800) 723-0607 or (402) 220-2658. The replay will also be available on the website.

About The Goodyear Tire & Rubber Company

Goodyear is one of the world's largest tire companies. It employs about 60,000 people and manufactures its products in 48 facilities in 19 countries around the world. Its two Innovation Centers in Akron, Ohio, and Colmar-Berg, Luxembourg, strive to develop state-of-the-art products and services that set the technology and performance standard for the industry. For more information about Goodyear and its products, go to www.goodyear.com/corporate.

SOURCE The Goodyear Tire & Rubber Company

Share this article